期刊文献+

HIV感染者/AIDS患者近期预后危险因素的分析 被引量:9

The Research of Prognosis Risk Factors in Recent Period for HIV-infected Individuals and Acquired Immunodeficiency Syndrome Patients
原文传递
导出
摘要 目的探讨HIV感染者/AIDS患者(HIV/AIDS)近期预后的危险因素。方法回顾性分析164例HIV/AIDS患者的基线(性别、年龄、婚姻状况、传播途径、WHO临床分期和CD4+T淋巴细胞)及随访资料(是否开始HAART、预后状态和生存时间),观察期为48周,用Kaplan-Meier法计算平均生存期,生存函数曲线的比较用Log Rank检验。结果 164例HIV/AIDS患者在随访期内生存105例(64.02%),死亡59例(35.98%),其中24周内累计死亡55例(93.22%),死亡原因均为AIDS相关性疾病。本研究中年龄≤50岁组的平均生存期(269d)高于年龄>50岁组(209d)(P<0.05);男性组的平均生存期(226d)小于女性组(303d)(P<0.05);WHO临床分期I,II和III期组的平均生存期(330d)明显高于WHO临床分期Ⅳ期组(172d)(P<0.05);基线CD4+>50个/mm3组的平均生存期(297d)也高于基线CD4+≤50个/mm3组(205d)(P<0.05);未开始HAART组平均生存期只有48d,明显低于已接受HAART组(336d)(P<0.05);性传播者的平均生存期(253d)和血液传播者(274d)相近(P>0.05)。结论确诊HIV/AIDS时的年龄>50岁、男性、WHO临床IV期、基线CD4+≤50个/mm3和未开始HAART是影响本地区HIV/AIDS患者近期预后的危险因素。 Objective To investigate risk factors of prognosis for HIV-positive individuals and AIDS patients. Methods The general and follow-up data of 164 cases of HIV-infected individuals and AIDS patients(HIV/AIDS) were included for retrospective analysis. The survey last for 48 weeks. The average survival time was calculat- ed by Kaplan Meier method. The survival function curve was compared with the Log Rank test. Results 105 eases( 64.02% ) survived and 59 cases( 35.98% ) died during the follow-up period. The death rate reached 93.22% (55/59) during the first 24 weeks. The cause of death was AIDS related illnesses. The average sur- vival time of the younger group ( 〈 50 years of age) was 269 days, which was longer than 209 days of the 〉 50 year-old group( P 〈 0. 05 ). The average survival time of male group(226d) was less than that of female group(303d) , (P 〈0.05). The average survival time of WHO clinical stage Ⅰ, Ⅱ and Ⅲ group(330d) was significantly longer than that of WHO clinical stage IV (172d) ( P 〈 0. 05 ). The average survival time of the group whose baseline CD4^+ cells was of above 50/mma (297d) was longer than that of the group whose base- line CD4^+ was below 50/mm^3 (205d)(P 〈 0. 05 ). The average survival time of group who had not started HAART was 48d, however, that of patient who received HAART reached up to 336d( P 〈 0.05 ). The average survival time of patients transmitted by sex activities (253d) was similar to those infected by blood samples (274d) , (P 〉 0.05 ). Conclusion The prognosis risk factors in recent period for HIV/AIDS patients are age above 50 years old, WHO clinical stage IV, baseline CD4^+ ceils less than 50/mm^3 and non-HAART.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2014年第3期279-281,共3页 The Chinese Journal of Dermatovenereology
基金 柳州市科学研究与技术开发计划课题(编号2013J030401) 广西卫生厅计划课题(编号Z2013645)
关键词 人类免疫缺陷病毒 获得性免疫缺陷综合征 高效抗逆转录病毒治疗 预后 Human immunodeficiency virus (HIV) Acquired immune deficiency syndrome(AIDS) Highly active an-ti-retroviral therapy(HAART) Prognosis
  • 相关文献

参考文献14

二级参考文献160

  • 1王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:634
  • 2俸卫东,翁毓秋,韦琳,韦启后,单桂苏.广西柳州市艾滋病流行特征与流行趋势分析[J].公共卫生与预防医学,2006,17(5):6-7. 被引量:32
  • 3Chinese Medical Association and Chinese Center for Disease Control and Prevention.Guidelines for diagnosis and treatment of HIV/AIDS in China (2005)[J].Chinese Medical Journal,2006(19):1589-1608. 被引量:23
  • 4张福杰,曹韵贞,赵红心,等.国家免费艾滋病抗病毒药物治疗手册.2版.北京:人民卫生出版社,2008.
  • 5Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med, 1998,338:853-860.
  • 6Zhang F, Dou Z, Ma Y, et al. Five-Year Outcomes of the China national Free Antiretroviral Treatment Program. Ann Intern Med, 2009,151 : 242 -251.
  • 7Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr,2006,43:27-34.
  • 8Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med,2001,135 :17-26.
  • 9Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA, 2006,296 : 782 -793.
  • 10Zhang F, Dou Z, Yu L, et al. The Effect of Highly Active Antiretroviral Therapy on Mortality in HIV-Infected Former Plasma Donors in China. Clin Infect Dis ,2008,47:825-833.

共引文献438

同被引文献124

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部